Quratis, a Kosdaq-listed biotech company, said Friday that it has decided to establish a local corporation in the Philippines to tap into the country's tuberculosis vaccine market.Quratis has submitted an investigative new drug (IND) application for a phase 2b/3 clinical trial of “QTP101,” a TB vacc
CHA Biotech and Centenaire Biosciences have agreed to expand their collaboration on natural killer (NK) cell-antibody combination research. To this end, CHA Biotech transferred its NK cell therapeutic candidate to Centenaire Biosciences.The two companies will combine CHA Biotech's NK cells with Cent
Rophibio, a Korean biologics manufacturer, said Wednesday that it has entered into an agreement with Avantor, a U.S. biotech company, to supply raw materials and provide development support for a biosimilar referencing Keytruda.Keytruda (pembrolizumab) is MSD's blockbuster cancer medicine.The proces
FutureChem said Wednesday that its radiopharmaceutical candidate FC705 for treating prostate cancer has been granted Global Innovative Products on Fast Track (GIFT) designation by the Ministry of Food and Drug Safety.GIFT is a support system to bring highly innovative drugs, such as treatments for l
Lotte Biologics said it entered a partnership with Syracuse University to co-develop an educational program.Syracuse University, a U.S. private institution consisting of 13 schools and colleges, boasts distinguished alumni such as President Joe Biden and New York Governor Kathy Hochul.Under the acco
Bridge Biotherapeutics said Wednesday it has signed collaborative research agreements with the University of Colorado and Emory University to explore the potential for expanding the indications of BBT-877, an autotaxin inhibitor, as an immuno-oncology agent.The company added that the joint researche
Bluemtec has made a strategic investment in Medistaff, a secure messaging platform for physicians, becoming the latter’s second-largest shareholder.Bluemtec said Tuesday that it has recently acquired Medistaff's common stock, making it the company's second-largest shareholder. Bluemtec now owns 16.6
Celltrion held its annual general shareholders meeting on Tuesday with covering agenda items including approval of certain changes to the articles of incorporation, appointment of directors, appointment of outside directors to serve as auditors, appointment of auditors, approval of director compensa
The U.S. Congress’ proposal of the Biosecure Act, which targets Chinese biotech companies, will increase supply chain instability in the global pharmaceutical industry but it may benefit top CDMOs such as Lonza and Samsung Biologics in the mid- to long-term, a local brokerage said.According to a rep
AriBio said Monday that it has concluded an exclusive distribution agreement with a Chinese pharmaceutical company for AR1001, an oral treatment for Alzheimer's disease, in China. The agreement is valued at about 1.02 trillion won (5.6 billion RMB or $770 million).Under the exclusive sales contract
Geo-Young, Korea's largest pharmaceutical distributor, said Friday that it has signed a third-party logistics (3PL) contract with Samsung Bioepis for biosimilar drugs and started shipping the first batch.It was the first business agreement between the two companies, which calls for Geo-Young to carr
SK bioscience has begun exporting its cell-cultured influenza vaccine, SKY Cellflu, signaling the company's expansion into the Southeast Asian market and its entry into the southern hemisphere.SK bioscience said Thursday that it has shipped about 440,000 doses of SKY Cellflu to its Thai partner Biog
Merck said it would spend 300 million euros (about $328 million) to build a new bioprocessing plant in Daejeon, which would create around 300 additional jobs by the end of 2028. The decision marks the largest investment by Merck's Life Science business sector in the Asia-Pacific region to date, the
HLB has increased its stake in HLB Therapeutics, strengthening its control over the latter.HLB said Tuesday that it has purchased 673,000 shares of HLB Therapeutics, increasing its stake to 6.25 percent from 5.51 percent.HLB also purchased 660,000 shares last November. HLB Chairman Jin Yang-gon and
Samsung Life Science Fund, created jointly between Samsung Biologics, Samsung Bioepis, and Samsung C&T, and managed by Samsung Ventures, announced its investment in BrickBio, a preclinical-stage biopharmaceutical company focused on developing antibody-drug conjugate (ADC) drugs.The latest investment
CHA Biotech said Monday that it has signed a contract development and manufacturing organization (CDMO) agreement with Cell in Cells, a regenerative medicine cell therapies developer, to provide organoid treatment for cartilage diseases.Under the agreement, CHA Biotech will establish a cell bank of
Celltrion officially launched Zymfentra, also known as Remsima SC in Europe, in the U.S., last Friday.Zymfentra is the world's only subcutaneous (SC) form of infliximab, having received FDA approval in October of the previous year. Under the approval, the drug can treat moderate to severe active ulc
NeoImmuneTech said Friday that its board of directors has decided to establish a Polish subsidiary to prepare for full-scale clinical trials in the European market.NeoImmuneTech expects that the Polish subsidiary's possible designation as a European small and medium enterprise (SME) will enable it t
In a move reflecting the intricate dance between branding, legal challenges, and market positioning, two Korean biotech companies, LegoChem Biosciences and Helixmith, have announced changes to their corporate identities.LegoChem Biosciences will soon undergo a transformation to LigaChem Biosciences,
NGeneBio, a company specializing in next-generation sequencing-based precision diagnostic platforms, said Wednesday that it has signed a business agreement with Genolution, a molecular diagnostics company."We signed this business agreement to provide NGS (next-generation sequencing) testing services